Cargando…

Zolpidem-induced sneezing: A case report of positive rechallenge

INTRODUCTION: Zolpidem, as an imidazopyridine, is a widely prescribed drug in clinical practice for short-term treatment of insomnia. Nevertheless, there have been a number of cases associated with the adverse effects of the stated drug recently. Further to the existing reports of adverse reactions...

Descripción completa

Detalles Bibliográficos
Autores principales: Amraei, Razie, Parsa, Abdolhamid, Babaeian, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851732/
https://www.ncbi.nlm.nih.gov/pubmed/29489694
http://dx.doi.org/10.1097/MD.0000000000009918
_version_ 1783306444827787264
author Amraei, Razie
Parsa, Abdolhamid
Babaeian, Mohammad
author_facet Amraei, Razie
Parsa, Abdolhamid
Babaeian, Mohammad
author_sort Amraei, Razie
collection PubMed
description INTRODUCTION: Zolpidem, as an imidazopyridine, is a widely prescribed drug in clinical practice for short-term treatment of insomnia. Nevertheless, there have been a number of cases associated with the adverse effects of the stated drug recently. Further to the existing reports of adverse reactions to zolpidem, the current script is going to report a case in which zolpidem has induced acute repetitive sneezes. CONCLUSIONS: A high dose of zolpidem may contribute to interruption to the neurons function involved in the sneezing pathway.
format Online
Article
Text
id pubmed-5851732
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-58517322018-03-21 Zolpidem-induced sneezing: A case report of positive rechallenge Amraei, Razie Parsa, Abdolhamid Babaeian, Mohammad Medicine (Baltimore) 5750 INTRODUCTION: Zolpidem, as an imidazopyridine, is a widely prescribed drug in clinical practice for short-term treatment of insomnia. Nevertheless, there have been a number of cases associated with the adverse effects of the stated drug recently. Further to the existing reports of adverse reactions to zolpidem, the current script is going to report a case in which zolpidem has induced acute repetitive sneezes. CONCLUSIONS: A high dose of zolpidem may contribute to interruption to the neurons function involved in the sneezing pathway. Wolters Kluwer Health 2018-03-02 /pmc/articles/PMC5851732/ /pubmed/29489694 http://dx.doi.org/10.1097/MD.0000000000009918 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-sa/4.0 This is an open access article distributed under the Creative Commons Attribution-ShareAlike License 4.0, which allows others to remix, tweak, and build upon the work, even for commercial purposes, as long as the author is credited and the new creations are licensed under the identical terms. http://creativecommons.org/licenses/by-sa/4.0
spellingShingle 5750
Amraei, Razie
Parsa, Abdolhamid
Babaeian, Mohammad
Zolpidem-induced sneezing: A case report of positive rechallenge
title Zolpidem-induced sneezing: A case report of positive rechallenge
title_full Zolpidem-induced sneezing: A case report of positive rechallenge
title_fullStr Zolpidem-induced sneezing: A case report of positive rechallenge
title_full_unstemmed Zolpidem-induced sneezing: A case report of positive rechallenge
title_short Zolpidem-induced sneezing: A case report of positive rechallenge
title_sort zolpidem-induced sneezing: a case report of positive rechallenge
topic 5750
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851732/
https://www.ncbi.nlm.nih.gov/pubmed/29489694
http://dx.doi.org/10.1097/MD.0000000000009918
work_keys_str_mv AT amraeirazie zolpideminducedsneezingacasereportofpositiverechallenge
AT parsaabdolhamid zolpideminducedsneezingacasereportofpositiverechallenge
AT babaeianmohammad zolpideminducedsneezingacasereportofpositiverechallenge